ImmusanT, Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) (NCT03644069) | ImmusanT, Inc. | 2018-08-06 |
| Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease (NCT03543540) | ImmusanT, Inc. | 2018-05-01 |
| Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease (NCT02528799) | ImmusanT, Inc. | 2015-08-01 |
Track ImmusanT, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.